Advertisement
GCTK vs SIBN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCTK is a StrongBuy and SIBN is a Buy.
GCTK in upward trend: price may jump up because it broke its lower Bollinger Band on October 02, 2026
GCTK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 41 of 47 cases where GCTK's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 87%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for GCTK just turned positive on September 30, 2026. Looking at past instances where GCTK's MACD turned positive, the stock continued to rise in 37 of 47 cases over the following month. The odds of a continued upward trend are 79%.
Following a +3.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where GCTK advanced for three days, in 151 of 188 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GCTK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for GCTK entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 98 (best 1 - 100 worst), indicating slightly worse than average price growth. GCTK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.348) is normal, around the industry mean (2.874). P/E Ratio (0.035) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (1.200) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (40.124).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GCTK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
SIBN in upward trend: 10-day moving average broke above 50-day moving average on October 05, 2026
The 10-day moving average for SIBN crossed bullishly above the 50-day moving average on October 05, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 86%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on SIBN as a result. In 58 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 72%.
The Moving Average Convergence Divergence (MACD) for SIBN just turned positive on October 05, 2026. Looking at past instances where SIBN's MACD turned positive, the stock continued to rise in 39 of 48 cases over the following month. The odds of a continued upward trend are 81%.
SIBN moved above its 50-day moving average on October 05, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.97% 3-day Advance, the price is estimated to grow further. Considering data from situations where SIBN advanced for three days, in 212 of 277 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
The Aroon Indicator entered an Uptrend today. In 138 of 194 cases where SIBN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.
Bearish Trend Analysis
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SIBN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
SIBN broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.299) is normal, around the industry mean (2.874). P/E Ratio (-65.333) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (3.801) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. SIBN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 73 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SIBN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
GCTK | SIBN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 95 | 73 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 99 Overvalued | 9 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 93 | |
PRICE GROWTH RATING 1..100 | 98 | 37 | |
P/E GROWTH RATING 1..100 | 93 | 73 | |
SEASONALITY SCORE 1..100 | 90 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SIBN's Valuation (9) in the Medical Specialties industry is significantly better than the same rating for GCTK (99) in the null industry. This means that SIBN’s stock grew significantly faster than GCTK’s over the last 12 months.
SIBN's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as GCTK (100) in the null industry. This means that SIBN’s stock grew similarly to GCTK’s over the last 12 months.
SIBN's SMR Rating (93) in the Medical Specialties industry is in the same range as GCTK (100) in the null industry. This means that SIBN’s stock grew similarly to GCTK’s over the last 12 months.
SIBN's Price Growth Rating (37) in the Medical Specialties industry is somewhat better than the same rating for GCTK (98) in the null industry. This means that SIBN’s stock grew somewhat faster than GCTK’s over the last 12 months.
SIBN's P/E Growth Rating (73) in the Medical Specialties industry is in the same range as GCTK (93) in the null industry. This means that SIBN’s stock grew similarly to GCTK’s over the last 12 months.
| GCTK | SIBN | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 78% |
| Stochastic ODDS (%) | N/A | 1 day ago 75% |
| Momentum ODDS (%) | N/A | 1 day ago 72% |
| MACD ODDS (%) | 1 day ago 79% | 1 day ago 81% |
| TrendWeek ODDS (%) | 1 day ago 90% | 1 day ago 77% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 79% |
| Advances ODDS (%) | 16 days ago 80% | 1 day ago 77% |
| Declines ODDS (%) | 1 day ago 90% | 4 days ago 76% |
| BollingerBands ODDS (%) | 1 day ago 87% | 1 day ago 75% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 71% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GCTK’s FA Score shows that 0 FA rating(s) are green while SIBN’s FA Score has 1 green FA rating(s).
- GCTK’s FA Score: 0 green, 5 red.
- SIBN’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GCTK’s TA Score shows that 3 TA indicator(s) are bullish while SIBN’s TA Score has 6 bullish TA indicator(s).
- GCTK’s TA Score: 3 bullish, 2 bearish.
- SIBN’s TA Score: 6 bullish, 3 bearish.
Price Growth
GCTK (@Medical/Nursing Services) experienced а -27.98% price change this week, while SIBN (@Medical/Nursing Services) price change was +6.93% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.
Reported Earning Dates
GCTK is expected to report earnings on Nov 12, 2026.
SIBN is expected to report earnings on Nov 02, 2026.
Industries' Descriptions
@Medical/Nursing Services (-1.62% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
GCTK and
Correlation & Price change
A.I.dvisor indicates that over the last year, GCTK has been loosely correlated with NUWE. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if GCTK jumps, then NUWE could also see price increases.
| Ticker / NAME | Correlation To GCTK | 1D Price Change % | ||
|---|---|---|---|---|
| GCTK | 100% | -6.78% | ||
| NUWE - GCTK | 43% Loosely correlated | -8.19% | ||
| SIBN - GCTK | 31% Poorly correlated | +3.55% | ||
| QTRX - GCTK | 30% Poorly correlated | +1.79% | ||
| LAB - GCTK | 25% Poorly correlated | -2.22% | ||
| IMDX - GCTK | 24% Poorly correlated | -5.96% | ||
More | ||||
SIBN and
Correlation & Price change
A.I.dvisor indicates that over the last year, SIBN has been loosely correlated with ATEC. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if SIBN jumps, then ATEC could also see price increases.
| Ticker / NAME | Correlation To SIBN | 1D Price Change % | ||
|---|---|---|---|---|
| SIBN | 100% | +3.55% | ||
| ATEC - SIBN | 54% Loosely correlated | +4.60% | ||
| OFIX - SIBN | 46% Loosely correlated | +2.57% | ||
| MDT - SIBN | 45% Loosely correlated | +3.83% | ||
| STE - SIBN | 42% Loosely correlated | +4.85% | ||
| PODD - SIBN | 41% Loosely correlated | +4.38% | ||
More | ||||